Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Ganglioneuroblastoma 2Neuroblastoma 1Neoplasms 1

Interventions

pembrolizumab 16Bevacizumab 11Carboplatin 10Nivolumab 8Pemetrexed 7Temozolomide 6atezolizumab 5Standard of Care 5Prednisone 5Exercise 5Cyclophosphamide 5Cetuximab 5durvalumab 4abemaciclib 4Paclitaxel 4Dexamethasone 4Cisplatin 4Blood Specimen Collection 4dostarlimab 3daratumumab 3cabozantinib 3Rituximab 3Oxaliplatin 3Metformin 3Leucovorin 3Lenalidomide 3Ipilimumab 3Fluorouracil 3Doxorubicin 3Docetaxel 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × Isotretinoin × 30 days × Clear all
NCT03611595 2026-05-27

Cabozantinib in Combination With 13-cis-Retinoic Acid in Children With Relapsed or Refractory Solid Tumors

University of California, San Diego

Phase 1 Completed
15 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡